IDENTIFICATION OF SIDE EFFECTS OF USE OF ANTI TUBERCULOSIS DRUGS IN PADANG SERAI AND TELAGA DEWA HEALTH CENTERS BENGKULU CITY 2024
DOI:
https://doi.org/10.36085/avicenna.v19i3.7452Abstract
Background: Tuberculosis is an infectious disease caused by Mycobacterium Tuberculosis, which can attack the lungs and other organs. Despite the progress that has been achieved, the number of tuberculosis cases is one of the biggest challenges faced and requires attention from all parties. Method: This study is a prospective observational study. The population in this study was 37 patients at the Telaga Dewa and Padang Serai Health Centers, Bengkulu City. The sampling technique was total sampling with inclusion criteria for patients seeking treatment at the Telaga Dewa and Padang Serai Health Centers, Bengkulu City. Results: The side effects of anti-tuberculosis drugs that occurred at the UPTD of the Padang Serai and Telaga Dewa Community Health Centers were red urine 100%, lack of appetite and nausea, vomiting 51.35%, weakness and pain 37.83%, stomach ache 32.43% , itching 29.72%, tingling and shortness of breath 16.21%, skin and eye color 13.51%, hearing loss 8.10%, visual disturbances, seizures and unconsciousness 2.7%. Conclusion; The majority of TB sufferers are male. The most frequent side effects of anti-tuberculosis drugs are red urine, lack of appetite, nausea, vomiting, pain.
Keywords : Side effects; OAT; tuberculosis,
References
Abbas, A. (2017). Monitoring Efek Samping Obat Anti-Tuberkulosis (OAT) Pada Pengobatan Tahap Intensif Penderita TB Paru Di Kota Makassar. Journal of Agromedicine and Medical Sciences, 3(1), 20–24.
Amal, S., Hidayah, H., & Cahyadi, A. (2021). Studi Farmakovigilans Terhadap ADRs Obat Antituberkulosis Pada Pasien TB Paru Di Rumah Sakit ‘X’ Karawang. Pharma Xplore Jurnal Ilmiah Farmasi, 6(1), 11–22. https://doi.org/10.36805/farmasi.v6i1.1445
Anisa Rahayu Eka Putri, & Suwendar. (2022). Monitoring Efek Samping Obat Antituberkulosis (OAT) pada Pasien Tuberkulosis Kategori I di UPT Puskesmas Bayongbong Kabupaten Garut. Bandung Conference Series: Pharmacy, 2(2), 409–417. https://doi.org/10.29313/bcsp.v2i2.4231
Dasopang, E. S., Hasanah, F., & Nisak, C. (2019). ANALISIS DESKRIPTIF EFEK SAMPING PENGGUNAAN OBAT ANTI TUBERCULOSIS PADA PASIEN TBC DI RSUD Dr. PIRNGADI MEDAN. Jurnal Penelitian Farmasi & Herbal, 2(1), 44–49. https://doi.org/10.36656/jpfh.v2i1.180
Dewi, V. N. L., & Anggraeni, F. D. (2014). Ekstrak Jahe Lebih Efektif Dalam Mengurangi Mual Pada Kehamilan Trimester I Dibandingkan Dengan Vitamin B6. Media Ilmu Kesehatan, 3(3).
Farhanisa., et al. (n.d.). Kejadian Efek Samping Obat Anti Tuberkulosis (Oat) Kategori 1 Pada Pasien Tb Paru Di Unit Pengobatan Penyakit Paru-Paru (Up4) Provinsi Kalimantan Barat. 1–17.
Isbaniayah, F. (2021). Tuberkulosis Pedoman Diagnosis dan Penatalaksanaan di Indonesia. In Perhimpunan Dokter Paru Indonesia (Vol. 001, Issue 2014).
Kementerian Kesehatan Republik Indonesia. (2019). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. Jurnal Kajian Pendidikan Ekonomi Dan Ilmu Ekonomi, 2(1), 1–19.
Kementrian Kesehatan Republik Indonesia. (2016). Pedoman Penanggulangan Tuberkulosis.
Khairunnisa, S. A., & Puspitasari, I. M. (2023). Review : Efek Samping Obat Antituberkulosis Oral Lini Pertama Pada Anak. Farmaka, 21(2), 197–205.
Kristini, T., & Hamidah, R. (2020). Potensi Penularan Tuberculosis Paru pada Anggota Keluarga Penderita. Jurnal Kesehatan Masyarakat Indonesia, 15(1), 24. https://doi.org/10.26714/jkmi.15.1.2020.24-28
Musdalipah; Nurhikmah, Eny; Karmilah, Fakhrurazi, M. (2018). Efek Samping Obat Anti Tuberkulosis ( Oat ) Dan Penanganannya Pada Pasien Tuberkulosis ( Tb ) Di Puskesmas Perumnas Kota Kendari. Jurnal Imiah Manuntun, 4(1), 67–73.
Ningsih, A. S. W., Ramadhan, A. M., & Rahmawati, D. (2022). Kajian Literatur Pengobatan Tuberkulosis Paru dan Efek Samping Obat Antituberkulosis di Indonesia. Proceeding of Mulawarman Pharmaceuticals Conferences, 15, 231–241. https://doi.org/10.25026/mpc.v15i1.647
Nova, T., & Purwoko, B. (2024). Hubungan lama terapi dengan efek samping pengobatan tb-mdr. 13(3), 111–116.
Nugrahaeni, D. K., & Malik, U. S. (2013). Analisis Penyebab Resistensi Obat Anti Tuberkulosis. Jurnal Kesehatan Masyarakat, 8(2), 113–120.
Oktavidiati, E., Sandos Yedilau, Nopia Wati, & Riska Yanuarti. (2023). Pelaksanaan Klinik Sanitasi Lingkungan Puskesmas Jalan Gedang Kota Bengkulu. Avicenna: Jurnal Ilmiah, 17(3), 196–211. https://doi.org/10.36085/avicenna.v17i3.4582
Rasdianah, N., Madania, Tutoli, T. S., Abdulkadir, W. S., Hidayat, A., & Suwandi, T. B. A. (2022). Studi Efek Samping Obat Antituberkulosis ( OAT ) Pada Pasien TB Paru. Journal Syifa Sciences and Clinical Research (JSSCR), 4(3), 707–717.
Rosamarlina, R., Lisdawati, V., Banggai, C. E., Darayani, D., Pakki, T. R., Rogayah, R., & Murtiani, F. (2019). Monitoring Efek Samping Obat Anti Tuberkulosis di Poli TB DOTS RSPI Prof. Dr. Sulianti Saroso. The Indonesian Journal of Infectious Diseases, 5(2), 10. https://doi.org/10.32667/ijid.v5i2.81
Savitri, E. W., Sius, U., & Sudarso, M. (2021). Hubungan efek samping OAT dengan motivasi pasien TB paru untuk melanjutkan pengobatan. Holistik Jurnal Kesehatan, 15(3), 391–404.
https://doi.org/10.33024/hjk.v15i3.5298
World Health Organization. (2020). Are Updated Every Year . for the Tuberculosis. In Global Tuberculosis Report.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
